A clinicopathological study was conducted on 351 bone marrow trephine biopsies derived from 124 patients with chronic myeloid leukemia (CML) at standardized endpoints before and after allogeneic bone marrow transplantation (BMT). The purpose was to investigate quantitative changes of the nucleated erythroid precursor cell population and other associated features such as resident bone marrow macrophages and myelofibrosis and to elucidate their relevance on engraftment parameters. Monoclonal antibodies were applied for the identification of erythroid precursors and the labeling of mature macrophages; argyrophilic (reticulin-collagen) fibers were demonstrated by a silver impregnation technique. Following morphometric analysis of the pregraft bone marrow specimens statistical evaluation was in line with an adverse correlation between early to moderate reticulin fibrosis and amount of erythropoiesis. Moreover, a significant relationship was calculable between numbers of erythroid precursors and CD68 ؉ macrophages. After myelo-ablative therapy and BMT a pronounced decrease in cellularity and in the quantity of erythropoiesis was found. Comparable with the pregraft samples, a significant association between erythroid precursors and macrophages could be determined in the regenerating donor bone marrow. A pretransplant relevant reduction of the red cell lineage and a manifest (reticulin) myelofibrosis indicating an advanced stage of disease were accompanied by a significant delay to reach transfusion independence. This result was further supported by comparable findings in trephine biopsies performed in the early post-transplant period (second month after BMT). Corresponding examinations revealed an enhancement of fiber density and a decrease in erythropoiesis in those patients who did not conform with the usually accepted criteria for successful engraftment. In conclusion, compelling evidence has been produced that a significantly reduced amount of erythroid precursors, which is usually associated with myelofibrosis in the pretransplant bone marrow, exerts an impairment to undisturbed hematopoietic reconstitution. Moreover, a close spatial and numerical relationship between the erythroid lineage and resident (mature) macrophages is observable, in particular in the state of regeneration after BMT. Leukemia (2000) 14, 1378-1385.
Introduction
Stem cell and bone marrow transplantation (BMT) is generally believed to be the only form of therapy with the option to cure chronic myelogenous leukemia (CML). 1, 2 However, among other factors, outcome determined as capacity for unsupported hematopoietic reconstitution at day 30 following BMT is significantly influenced by progression of disease at onset and thus timing. [3] [4] [5] Regarding staging of chronic phase CML indicating a certain progress [4] [5] [6] ated or blastic phases, 7 some data have been accumulated that histopathology may offer supportive evidence. Follow-up studies on bone marrow histopathology together with clinical observations were in keeping with the finding that reduction in erythropoiesis 8 and extent of myelofibrosis [9] [10] [11] [12] may serve as valid parameters for the assessment of disease progression. Both variables have been shown to be significantly correlated and to exert a predictive value for survival. 8, 9, 11, 12 Contrasting the overall progress which has been achieved during the last decade concerning BMT in CML, 2, [13] [14] [15] [16] [17] [18] hardly any information exists about bone marrow morphology following marrowablative pretransplant regimens and the regeneration of hematopoiesis. In particular, this lack of knowledge applies to erythroid precursors in the pre-and post-transplant period and the problem whether a greatly reduced erythropoiesis before BMT exerts a relevant influence on engraftment. Because there is clear-cut evidence for an important functional role of the central resident (mature) macrophages of erythroblastic islets in iron turnover, hemoglobin synthesis, erythropoietin production and phagocytosis of the expelled erythroblastic nuclei, 19 this cell lineage deserves special attention in the context of erythropoietic regeneration. For this reason, the purpose of the present study was focused on histopathology characterizing the reconstitution of erythropoiesis including the macrophage population and associated changes of the fiber content during the critical phase of marrow engraftment in CML. To elucidate the putative impact of these features on BMT biology, appropriate analysis was carried out by histochemical and morphometric methods on repeatedly performed bone marrow trephine biopsies at standardized endpoints accompanied by corresponding clinical data.
Materials and methods

Patients
The series considered for study was based on a retrospective evaluation of 124 patients presenting with first chronic (stable) phase of Philadelphia chromosome-positive (Ph 1ϩ ) CML. Patients received unmanipulated marrow grafts from HLAidentical family or alternate donors at a single referral transplantation center following standard procedures.
14 Details regarding, clinical findings and treatment characteristics are summarized in Table 1 . As may be easily derived from Table 1 homogeneity of our cohort concerning specifications of certain characteristics is established by showing about 80% sibling donors, in more than 70% an identical HLA constellation and the same conditioning regimen in 90% of patients. Endpoint of hematological reconstitution with normal graft function was assumed if patients achieved transplant-derived absolute neutrophil counts greater than 0.5 × 10 9 /l and self-sustaining thrombocyte counts greater than 20.0 × 10 9 /l until day 30 following BMT. Delayed engraftment was diagnosed if these thresholds were not present at that time and graft failure was established if cell counts did not reach these levels at standardized endpoints (Table 2 ) and were associated with extreme hypocellularity of bone marrow biopsies. Pretransplant busulfan (BU) and hydroxyurea (HU) treatment was generally adapted to peripheral leukocyte counts and carried out using conventional dosages of these agents. Following BMT a successful engraftment according to the above mentioned generally accepted criteria [13] [14] [15] [16] [17] [18] was found in 93 patients, a delayed hematopoietic reconstitution in 31 including and failure in three patients. During an observation time of more than 10 years a leukemic relapse occurred in 19 patients. Two patients with transplant-related mortality, ie death within 30 days after BMT (day 0) were excluded from our calculations.
Bone marrow biopsies
Fixation of bone marrow biopsies was carried out in a lowconcentrated phosphate-buffered formaldehyde solution (2-3%) for 12-48 h. Further processing included decalcification Leukemia for 3-4 days in 10% buffered ethylene-diamine tetra-acetic acid (EDTA), pH 7.2, paraffin embedding, and employment of several routine staining techniques, involving Giemsa, PAS (periodic acid Schiff reagent), naphthol-AS-D-chloroacetate esterase, Perls' reaction for iron and finally a silver impregnation method (Gomori's technique) for the assessment of argyrophilic (reticulin-collagen) fiber density. For specific staining of nucleated erythroid precursor cells the monoclonal antibody Ret40f (anti-glycophorin C) was used 20 and for the CD68 ϩ mature-resident macrophage population PG-M 1 .
21
Monoclonal antibodies and other reagents were purchased from Dako-Diagnostica (Hamburg, Germany). Details of staining procedures (APAAP-method) were reported in a previous communication.
12,21
Morphometry
Following immunostaining and silver impregnation morphometric analysis was performed by two manual optic planimeters (MOP-A-MO1-Kontron and VIDAS-Zeiss-Kontron, Carl Zeiss, Oberkochen, Germany) with a standard program set (Kontron software, Kontron, Eching, Germany) on large trephine biopsies with an artefact-free mean marrow area of 14.5 × 4.8 mm 2 . Frequencies of erythroid precursors and macrophages were calculated per square millimeter (mm 2 ) total marrow area by regarding the age-or therapy-related adipose tissue and also per hematopoiesis (cellularity). After silver impregnation procedures density of argyrophilic (reticulincollagen) fibers was determined by the point-intersection method using an ocular grid. Thus the amount of fibers was expressed as intersections (i) per area (mm 2 ) of total bone marrow and also per hematopoietic tissue (cellularity). Reference to cellularity was necessary to focus on the areas relevant for hematopoietic reconstitution and further to avoid the erroneous impression of a significant reduction of these variables due to the expansion of adipose tissue or interstitial edema. This feature was prominent following marrow-ablative therapy and during the post-transplant period in those patients with delayed hematopoietic recovery.
Statistics
Because in our series of 124 patients bone marrow biopsies were performed at significantly different intervals of the preand post-transplant period, a comprehensively conducted evaluation and comparison of data required a computation of defined endpoints within standardized intervals. This was achieved by selecting a total of 351 examinations which had been performed at certain short periods, in particular following BMT (Table 2) . For this reason, morphometric analysis was focused on bone marrow trephines at these endpoints. In accordance with a widely applied semiquantitative scoring system for myelofibrosis 22 a more than three-fold increase in the normal density of argyrophilic (reticulin-collagen) fibers 12 was consistent with an early to moderate myelofibrosis and readily recognizable in corresponding bone marrow samples. Statistical analysis included computation of the Mann-Whitney U test to compare histomorphological parameters according to engraftment status. 
Results
In the diagnostic pretreatment biopsies of the CML bone marrow erythroblastic islets were dispersed among the prevalent neutrophil granulopoiesis ( Figure 1a ) and were usually very small (Figure 1b) . Following various pretransplant therapeutic regimens (Table 1) examinations performed shortly before myelo-ablative therapy and BMT revealed no significant changes in the total amount of erythroid precursors or the hemoglobin/hematocrit level in the majority of patients. Therapy with IFN-␣ resulted in a slight to moderate increase in erythropoiesis. However, probably due to the high standard deviation in comparison to HU this improvement was not significant. Statistical analysis was in keeping with an adverse correlation (r = −0.506, P Ͻ 0.01) between manifest early to moderate reticulin myelofibrosis (Figure 2a) found in 33 patients of our series and the amount of erythropoiesis and splenomegaly. In 18 patients the Sokal index revealed an intermediate or high pretransplant risk profile (Table 1) . Contrasting the low risk group these patients displayed a tendency for a reduced amount of erythropoiesis and an enhanced reticulin content before BMT, thus signalling a more advanced stage of disease. Moreover, in the pregraft bone marrow a significant relationship was determinable between the quantity of nucleated erythroid precursors and the CD68 ϩ macrophage population (r = 0.515, P Ͻ 0.01) calculated per area of hematopoiesis.
After BMT (day 0) histopathology was characterized by a conspicuous decrease in cellularity accompanied by an expansion of the adipose tissue (Figure 1c ). Starting at approximately day 10 there was a proteinaceous interstitial edema containing a variable number of tiny to small-sized erythropoietic islets and a few dispersed megakaryocytes (Figure 1d ) or fat tissue with groupings of erythroid precursors (Figure 1e ). In a number of patients with pretransplant manifest myelofibrosis (Figure 2a ) an insidious increase in reticulin fibers was detectable in the regenerating areas of hematopoiesis after about 3-4 months (Figure 2b) . Again a significant relationship (r = 0.550, P Ͻ 0.01) between quantity of erythroblasts and resident macrophages could be calculated in the post-transplant specimens immediately after BMT corresponding with endpoint (3) in Table 2 . This finding was not only demonstrable by morphometric-statistical computation, but also by histochemistry exhibiting a close spatial relationship between areas of reconstituting erythropoiesis and centrally localized macrophages (Figure 2c ). Depending on the standardized selection of patients with short intervals between the posttransplant biopsies, a continuously occurring increase in the amount of regenerating erythropoiesis was evident and, although supported by intensive transfusion therapy with packed cells, was accompanied by a corresponding rise of hemoglobin/hematocrit values ( Table 2) . Dynamics of regenerating erythropoiesis were closely linked with the other cell lineages which has been explicitly calculated for megakaryopoiesis (Figure 1d ). Statistical evaluation of the amount of CD61 ϩ megakaryocytes after BMT revealed a comparable capacity for recovery including the finding that a significantly reduced number was also in keeping with delayed engraftment in the early post-transplant period. Some patients mostly with delayed engraftment showed clusters of large macrophages (scavenger macrophages) shortly after BMT (Figure 2e ). Probably depending on the small number of patients for this comparative study and the relatively high standard deviation, the amount of macrophages revealed only a tendency for increase per hematopoietic area in those patients with successful engraftment. In several patients four or even more sequential bone marrow biopsies were performed during the post-transplant period demonstrating the progression of erythropoietic recovery (Figure 3 ).
Significant correlations were calculable between pretransplant number of erythroid precursor cells and fiber density with delayed (31 patients) or successful (93 patients) engraftment (Table 3) . From these data it may be derived that a relevant pretransplant reduction in the quantity of erythropoiesis and early to moderate myelofibrosis, which are indicative for a more advanced stage of CML, exert an unfavorable impact on transfusion-independent hematopoietic recovery. Progressive changes in erythropoiesis and fiber density became most prominent when dividing our patients in two cohorts according to engraftment status. Thus additional evaluations of bone marrow features performed at standardized endpoints (endpoints 3 to 6 in Table 2 ) in the early post-transplant period produced confirmative evidence for alterations of regenerating hematopoiesis in accordance with completed or unsuccessful reconstitution. This finding is exemplarily shown about 2 weeks after day 30 at endpoint (4) in Table 2 . In comparison with the larger group of 41 patients already displaying an unsupported recovery of hematopoiesis significant differences regarding enhanced density of argyrophilic fibers and retarded erythropoietic regeneration were detectable in the remaining 11 patients who presented with the clinical findings of an delayed engraftment at that time (Figure 4) . On the other hand, statistical analysis revealed that this adverse effect regarding erythropoietic reconstitution was limited to the first 2 months after BMT and could not be ascertained at the later endpoints shown in Table 2 . Finally, of the 19 patients with a leukemic relapse during the observation time (about 10 years) only six showed a delayed engraftment Leukemia and therefore this cohort was not significantly different from the other patients. Analysis of the distinctive influence of donor-recipient relationship, HLA constellation, conditioning regimen and GVHD prophylaxis failed to disclose significant differences regarding the impact of erythropoiesis on engraftment. This result probably depends on the relative homogeneity of our series of patients derived from one transplantation center (Table 1) . Furthermore, similar findings were encountered regarding the ABO-blood group constellation. Patients with minor or major mismatch revealed no significant 
Discussion
A variety of host and donor factors has been repeatedly discussed as exerting a significant influence on allogeneic marrow engraftment. Amongst others donor-recipient relationships and histocompatibility, pretransplant therapy and the various conditioning regimens used to prepare the patients represent a major determinant of transplant outcome, 1, 2, [13] [14] [15] [16] [17] [18] depending significantly on the number and types of cells that survive. 23 The myelo-ablative therapy not only creates 'microenvironmental niches' for the differentiation and maturation of the donor hematopoietic stem cells, but also reduces the number of cells that may cause rejection. 24 In our series comprising about 80% sibling donors with identical HLA constellation from a single transplant center identical methods of myelo-ablative treatment were applied in 116 of the 124 patients (Table 1) . Following pregraft conditioning regimens in
Figure 3
Quantification and dynamics of erythroid precursors during allogeneic BMT in two patients with CML presenting with different levels of hemoglobin (HB) at onset and four sequential post-transplant bone marrow biopsies.
Table 3
Significant associations between pretransplant (endpoint 2, Table 1 
Figure 4
Relationship between myelofibrosis and erythropoiesis with engraftment parameters in allogeneic BMT for CML. Box and whisker plots were constructed for two groups of patients examined at day 38 Ϯ 4 after BMT (endpoint 4 in Table 2 ) according to their engraftment status (successful 41, delayed 11 patients).
vitro studies are in keeping with the finding that the microenvironment remains damaged not only quantitatively but also qualitatively several months after BMT, irrespective of any allo-immune reaction or postgraft immunosuppressive therapy. 25 Post-transplant hematopoietic impairment is the conseLeukemia quence of these changes which are expressed both by a reduced capacity of stem cells self-renewal and commitment towards erythroid-granulocytic and megakaryocytic lineages. A wealth of data has been gathered by the International Bone Marrow Transplant Registry (IBMTR) suggesting that advanced stages of CML may be determined by certain laboratory parameters (degree of anemia, blasts in the peripheral blood, increasing splenomegaly, persistent thrombocytosis). 4 In addition to these clinical variables, histological features such as myelofibrosis [8] [9] [10] [11] [12] and the amount of erythroid precursors 11 in the bone marrow have been previously postulated as indicators for progression. In this context convincing evidence has been produced that these parameters are characterized by significant mutual relationships and consequently exert their prognostic impact at first presentation of patients with CML. 12 Concerning this study which comprises a considerable number of patients with pretransplant chemo-and interferon therapy (Table 1) , it may be questioned whether these parameters of predictive value 4, [8] [9] [10] [11] [12] also exert an influence on engraftment. As could be shown in our series a significant pretransplant reduction in erythropoiesis was usually associated with myelofibrosis and in keeping with an intermediate to high risk profile according to the Sokal index and thus suggested a more advanced disease stage. This adverse constellation had an unfavorable impact on hematopoietic reconstitution according to the generally accepted criteria (Table 3) . [13] [14] [15] [16] [17] [18] Confirmative evidence for the validity of these features were additionally derived from bone marrow examinations performed shortly after the cut-off point of 30 days in the second month of the post-transplant period (Figure 4) . Regarding pretransplant myelofibrosis and its effect on platelet and red blood cell transfusion independence after BMT divergent results were consecutively reported from one study group. 26, 27 The failure of the authors to assess definitely an adverse influence of myelofibrosis on hematopoietic recovery may be significantly related to the striking heterogeneity of the series of patients investigated. Besides a variety of pretreatment modalities, conditioning regimens and donor-recipient relationships these also included leukemic disorders at very different stages of the disease process in addition to malignant lymphomas and CML. 27 Bone marrow stromal cells, in particular macrophages establish an intimate spatial contact and functional relationship with developing hematopoietic cells. [28] [29] [30] [31] [32] [33] [34] [35] [36] This feature plays a key role in the regulation and differentiation of progenitors of all lineages including erythroid precursors. Here macrophages create a peculiar anatomic unit, the erythroblastic islets. 31, 32 In recent years the concept of the centralresident macrophages providing essential mediators for the complex mechanism of generating mature erythrocytes has gained direct support from experimental findings. Despite much detailed speculation the critical function of the central mononuclear phagocytes characterizing the erythroblastic islets has been limited to their involvement in the degradation of the expelled nuclei and the presumed turnover of iron and other metabolites that are generated by this breakdown. [33] [34] [35] [36] [37] In addition to other putative mediators bone marrow macrophages produce and secrete erythropoietin (EPO) which exerts a key function by promoting late stage erythroid maturation. 19, 35 The significant correlation between the number of erythroid precursor cells and CD68 ϩ macrophages calculated per hematopoietic tissue in the post-transplant marrow specimens provides persuasive evidence for this distinctive functional association. Moreover, in this context it is noticeable that according to their myelo-monocytic progeny the pretrans-plant resident bone marrow macrophages in CML patients are Ph ϩ (bcr/abl ϩ ). 38, 39 These malignant macrophages are supposed to play a crucial role in the expansion of the leukemic cell clone and obviously contribute to the disturbances of the microenvironment in CML. 40 In conclusion, by an elaborate analysis of bone marrow features compelling evidence has been produced that in CML a significant reduction of erythropoiesis usually accompanied by myelofibrosis before allogeneic transplantation is in keeping with a more advanced stage of the disease process and thus greatly impairs engraftment. Following myelo-ablative therapy and BMT, a rapid reconstitution of erythroid islets is observable in patients with successful engraftment. In keeping with their important functional role during erythropoiesis a significant correlation between the amount of erythroid precursors and number of mature-resident macrophages is detectable in the pre-and also post-transplant period of hematopoietic recovery.
